QuartzBio | Sample and Biomarker Intelligence

Solving data intelligence challenges across R&D teams in clinical-phase biopharma

QuartzBio clients span biotechnology and pharmaceutical companies planning or conducting clinical trials across all therapeutic areas, including oncology, autoimmune disease, neurological disorders, and rare diseases. Many functional groups within these organizations rely on QuartzBio^® solutions.

Biospecimen(Sample) Operations and Biomarker Operations

Sample and biomarker operations teams use our Sample Intelligence Solution to gain real-time visibility across the entire sample lifecycle (transit, processing, testing, storage). They need to know what’s been collected, what’s missing, what’s consented, and what’s next – without having to wrangle multiple spreadsheets and bespoke technologies.

LEARN MORE

Translational Research

Translational research and clinical development teams use our Sample Intelligence Solution to gain visibility into sample quality and visibility into data availability to inform study decisions. For example, they need to know how many participants have pre- and post-treatment samples for data forecast generation.

These teams deploy our Biomarker Intelligence Solution to unify and interrogate all biological data generated during clinical programs. They use the resulting data asset to design clinical trials, develop and execute biomarker strategies, and gain insights into therapeutic mechanisms of action and resistance.

VIEW USE CASES & MORE

Clinical Operations

Clinical operations teams, including clinical data management teams, use our Sample Intelligence Solution to quickly identify discrepancies, maintain data quality, and manage queries into sample status and address them before database lock. They can also monitor site and vendor performance for real-time risk-based quality management and compliance with GCP requirements, including ICH E6(R3).

VIEW USE CASES

R&D IT Teams

R&D Information Technology (IT) teams use QuartzBio’s solutions to gain visibility into the entire data ecosystem to ensure that significant investments in patient enrollment, sample collection, and biomarker assay lab data generate value. In addition, they depend on QuartzBio’s compliant, secure, interoperability-first approach to ensure data integrity and governance–without having to rebuild their tech stack.

VIEW USE CASES & MORE

Supporting R&D teams by connecting the sample-to-biomarker value chain

Solving data intelligence challenges across R&D teams in clinical-phase biopharma

Learn how our solutions can transform your clinical programs